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ABSTRACT
A Translational Analysis of Renewal Following DRO with Human Subjects
Kacey R. Finch
Renewal is a type of behavioral relapse that is dependent on changes in contextual stimuli
in the environment. The current study investigated ABA renewal of responding that had been
previously reduced by a differential reinforcement of other behavior (DRO) procedure. ABA
renewal refers to the context associated with three phases of behavioral treatment; Context A is
present during baseline, Context B is present during treatment, and the post-treatment context
returns to Context A (i.e., renewal test). Undergraduate college students participated in a Zoom
video call during which they responded by clicking the mouse on a rectangle in a computer
program created in Visual Basic©. Each session consisted of baseline, DRO, and a renewal test
phase. In baseline, the target response was reinforced according to a fixed-interval (FI) 10-s
schedule. In the DRO phase, points were delivered contingent on refraining from clicking on the
target response during the 10-s omission interval. The same DRO contingency was in effect
during the renewal test. A change in the color of the screen background served as the contextual
change between baseline, treatment, and renewal test phases. This study assessed the occurrence
of renewal via visual inspection of graphed data. Renewal occurred for all six included
participants and was transient for five of six participants. Proportion of baseline and
reinforcement rate data are presented in addition to target and untargeted response rate.
Implications for clinical application and future research directions are discussed.
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A Translational Analysis of Renewal Following DRO with Human Subjects
Relapse is said to occur when a previously reduced response reemerges following
treatment. Relapse is common following the cessation of, or a challenge to, treatment procedures
and is often countertherapeutic (Wacker et al., 2011). For example, relapse of challenging
behavior (e.g., aggression) can be dangerous and can compete with more desirable alternative
responses (e.g., verbal requests for access to preferred items). Applied behavior analysts,
therefore, have a direct interest in promoting the persistence of treatment effects on socially
significant behavior and prevention of relapse of undesirable behavior across time. Two of the
most commonly studied types of relapse include resurgence (i.e., relapse of a response after
reinforcement conditions are worsened for an alternative response; Lattal et al., 2017) and
renewal (i.e., relapse of responding when the treatment conditions are carried out under different
conditions post-treatment; see Bouton & Todd, 2014 for a review). Resurgence and renewal have
been studied across basic literature with non-human animals and applied literature with human
subjects.
Kelley and colleagues (2015) define a context change as any stimulus change from the
environment that previously controlled behavior (e.g., changes in lights or olfactory stimuli in an
operant chamber, changes in the background color in a computer program, or changes in physical
location such as moving from a clinic to home). Renewal has been demonstrated in both human
(e.g., Ibanez et al., 2019; Liddon et al., 2018; Saini et al., 2018) and non-human animal
populations (e.g., Craig et al., 2018; Kelley et al., 2015). Renewal is typically evaluated in a
three-phase sequence that varies contextual stimuli across each phase (e.g., Liddon et al., 2018).
A recent study on the prevalence of clinical renewal assessed 182 context changes across 67
clients receiving outpatient applied behavior analysis services (Muething et al., 2020). Renewal
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occurred in 77 of 182 context changes (i.e., a 42.3% renewal occurrence rate). There are several
types of renewal based on the pattern of changes in contextual stimuli. In ABA renewal, the
target response (e.g., challenging behavior) is reinforced in Context A. In Context B, a responsesuppression procedure (e.g., extinction) is in effect for the target response. In the third phase,
Context A is re-introduced, and the response-suppression procedure remains in effect for the
target response. In ABC renewal, a third context is introduced in the third phase in which the
deceleration procedure is still in effect for the target response. Renewal is assessed based on
whether there is a recurrence of the target response in the third phase when the only change in
the environment is the context change.
Renewal of a previously reduced response is most commonly studied with extinction
(e.g., Bouton et al., 2011; Bouton & Ricker, 1994) or differential reinforcement of alternative
behavior (DRA) as the treatment method. In a series of experiments assessing ABA renewal,
Kelley and colleagues (2015) conducted a basic laboratory analysis with pigeons followed by a
translational analysis of ABA renewal with children with autism. The procedure for each
experiment was similar such that reinforcement was implemented for key pecking for pigeons in
baseline (Context A) of Experiment 1 and for on-task behavior for participants in Experiment 2.
In the treatment phase (Context B), extinction was in effect for key pecking and on-task
behavior, respectively. In the renewal test, the context was the same as baseline (i.e., Context A)
and extinction was still in effect. Renewal occurred for all six pigeons in Experiment 1 and both
participants in Experiment 2. This series of experiments demonstrated that renewal occurred in
similar patterns across basic and clinical settings in both populations. Notably, Experiment 2
showed renewal of a desirable response after it was extinguished in the second phase. In addition
to analyzing renewal of previously extinguished appropriate behavior, renewal of challenging
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behavior that is reduced in treatment is another important phenomenon to study. Renewal of
challenging behavior is often a barrier to generalization of treatment effects (e.g., alternative
behavior increased in treatment) and maintenance of behavior change. Identifying interventions
that are more resistant to relapse or methods to decrease the likelihood of relapse is crucial to
promoting maintenance and generalization of therapeutic effects (e.g., treatment-correlated
stimuli, multiple-context training; see Wathen & Podlesnik, 2018 for a review).
In a clinical example of renewal, a client may have a history of receiving attention from
parents following instances of aggression in the naturalistic environment (i.e., home). When the
client is brought to the treatment context (e.g., clinic) where they receive intensive applied
behavior analysis services, a DRA procedure may be implemented in which attention is provided
contingent on appropriate behavior and extinction is programmed for aggression (i.e., the adults
do not provide attention contingent on aggression). Following a successful decrease in
aggression at the clinic, returning to the original context in which the behavior was previously
reinforced (i.e., home) may result in renewal of aggression, even if the parents continue the same
intervention at home. Although DRA and extinction are common treatment components in
renewal analyses, another behavior-reduction technique implemented in clinical settings is
differential reinforcement of other behavior (DRO), which decreases a target response by
providing reinforcement contingent on the absence of the response (Homer & Peterson, 1980).
For example, if the goal is to reduce aggression, a DRO procedure might involve providing
access to attention contingent on the client refraining from engaging in aggression for the
duration of a predetermined interval (e.g., 2 min). Engaging in the response during the interval is
not reinforced, which is a key component of the response-suppressive effect of DRO (i.e.,
extinction, see Jessel & Ingvarsson, 2016 for a review of active mechanisms of DRO). While
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differential reinforcement procedures, such as DRO, are common and effective interventions for
decreasing challenging behavior, a response decreased via differential reinforcement is prone to
relapse following treatment (Lattal & St. Peter Pipkin, 2009). Challenging behavior has been
shown to relapse following differential reinforcement (e.g., functional communication training)
when it is implemented in different contexts or by different people, even with high treatment
integrity (e.g., caregivers implementing treatment at home following a reduction of the response
in a clinical setting; Schindler & Horner, 2005). This context-dependent relapse is an example of
renewal because contextual stimuli change from the original treatment environment to posttreatment environments. One hypothesis to explain the occurrence of renewal is that the effects
of extinction might be specific to the context in which the treatment was initially implemented
(Bouten & Todd, 2014).
Renewal is increasingly being studied in both translational and applied settings to learn
more about the role of contextual changes in the occurrence of relapse. Translational research
assessing renewal in human subjects has significantly increased in the last two years (e.g., Ibańez
et al., 2019; Kimball et al., 2020; Liddon et al., 2018; Novak et al., 2020; Robinson & Kelley,
2020; Schlund et al., 2020). Much of the existing literature on renewal assesses responding
following either an extinction or DRA treatment. Although DRO is a treatment strategy
implemented in clinical settings, less research has specifically investigated the prevalence of
renewal following a DRO procedure, and most of these DRO studies have been with non-human
animals as subjects.
Three studies have investigated renewal in rats as subjects following a DRO schedule in
the second phase of the renewal paradigm (Kearns & Weiss, 2007; Nakajima et al., 2002; Rey et
al., 2020b). Nakajima et al. (2002) compared responding between an ABA renewal test group
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and an AAA control group. In Phase 1, responding on the target lever was reinforced. The DRO
contingency was implemented in Context B for the ABA group and in Context A for the AAA
group. In the renewal test phase, DRO remained in effect for the target response such that the
only difference between the treatment phase and the renewal test phase for the ABA group was
the context. Renewal occurred in the ABA renewal test group and not in the AAA control group,
which provides support that renewal can be attributed to the context change in the ABA renewal
group from Phase 2 to Phase 3.
The remaining two non-human animal studies that assessed renewal following DRO
discontinued the DRO schedule in the renewal test and extinction was in effect for all responses
(Kearns & Weiss, 2007; Rey et al., 2020b). Using an ABA procedure, Kearns and Weiss
compared renewal following DRO and extinction in the second phase (Context B). The results
demonstrated that the level of renewal of responding eliminated by a DRO procedure was
significantly lower than the level of renewal following extinction. This suggests that behavior
reduced using a DRO schedule may be more resistant to relapse compared to extinction. In
another analysis, Rey et al. compared renewal following DRO and extinction in two groups of
rats. Renewal occurred for 15 out of 16 subjects in the DRO group and all 16 subjects in the
extinction group; the levels of renewal between groups were not directly compared in this study.
The results of these three studies demonstrate that renewal is common following DRO. Although
the results from Kearns and Weiss suggest that there may be differences in the levels of renewal
following different response-suppression procedures, additional research is needed to determine
whether such differences consistently occur.
Only one known experiment has assessed renewal following a DRO procedure with
human subjects (Vila et al., 2020). In this study, experimenters arranged a video game in which
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participants were asked to shoot at virtual spaceship enemies. Two responses were differentially
consequated across the three phases of a trial-based renewal arrangement. In Phase 1, both
responses were reinforced according to a variable-interval (VI) 4-s schedule in eight trials, and
all trials ended after a single reinforcer delivery. In Phase 2, a DRO schedule was in effect for
one response with a 4-s omission interval for the next eight trials. Participants in the ABA group
experienced Phase 2 in a different context than Phase 1; the context change included a different
colored computer and keyboard and different colored furniture in the experimental room. The
context did not change from Phase 1 to Phase 2 for the AAA group. The renewal test phase
occurred in Context A and consisted of one trial in which the DRO was discontinued and no
reinforcers were delivered for responding. The response associated with the DRO schedule
increased from Phase 2 to the Phase 3 test trial in the ABA group but did not increase for the
AAA control group, suggesting that renewal occurs in human subjects following response
reduction by a DRO procedure. However, it is unclear whether the context change alone is
responsible for the occurrence of renewal because the reinforcement schedule and the context
changed from Phase 2 to Phase 3. Another limitation of this study is that testing renewal in a
single trial precludes an evaluation of the persistence and pattern of relapse following a sustained
change in context.
Most renewal arrangements implement extinction in the treatment phase and then
continue the implementation of extinction in the renewal test phase (Saini & Mitteer, 2020). Of
the four studies on renewal following DRO, three discontinued DRO and implemented extinction
of all available responses in the renewal test phase (Kearns & Weiss, 2007; Rey et al., 2020b;
Vila et al., 2020). This arrangement introduces a confound of two variable changes from the
treatment phase to the renewal test phase (the context and the reinforcement schedule). One
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study, however, demonstrated the occurrence of renewal when the same DRO contingency
continued from the treatment phase during the renewal test phase (Nakajima et al., 2002). This
arrangement isolated the context stimulus as the only variable that changed from the treatment
phase to the renewal phase and mirrors the common clinical occurrence that the intervention
remains in effect post-treatment (e.g., the parents may be trained to implement the DRO schedule
at home).
The purpose of this experiment was to further assess the occurrence of ABA renewal
following a DRO procedure (rather than the more common DRA or extinction procedures) to
reduce a target response in a highly controlled human-operant arrangement. The current
experiment extended previous research by arranging a renewal test in which the DRO
contingency from the treatment phase remained in effect during the renewal test phase (e.g.,
Nakajima et al., 2002) and extended the duration of the renewal test beyond the single-trial test
by Vila et al. (2020). We conducted the current experiment via Zoom to assess the utility of
virtual platforms for efficiently gathering behavioral data on relapse (e.g., Robinson & Kelley,
2020).
Method
Participants and Setting
Ten undergraduate students (six female and four male) from WVU ages 18–22 participated
in virtual sessions and received course credit in a psychology course. Nine participants reported
their race as White, and one participant reported their race as Black. Requirements to participate
included access to a computer equipped with a mouse or trackpad, speakers or headphones, a
webcam, a microphone, an internet connection, and Zoom for video calling. We conducted all
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sessions through Zoom, and the participants attended the sessions from their home or other
personal work area using a personal computer. The experimental task was screen shared with the
participant via Zoom, and the participant was given remote control of the screen such that they
could interact with the computer program using their mouse and keyboard.
Apparatus
The experimental task was programmed in Microsoft Visual Basic© and included one
6.0-cm by 1.3-cm stationary black rectangle in the middle of the screen. The participant clicked
on a white start button at the beginning of the session to start the program. Following a mouse
click on the black rectangle (i.e., target response), the rectangle turned gray for 100 ms. When
the participant met the criterion for earning a point according to the fixed-interval (FI) 10-s
schedule or the DRO 10-s schedule, the rectangle temporarily disappeared, a box appeared that
said “+1” and the participant clicked a button below the text that said, “collect point” (i.e.,
consummatory response). During the consummatory response, the omission interval in the DRO
phase and the interval in the FI schedule were paused. Clicks on the background area of the
screen resulted in no programmed consequences across all three phases. There was a cumulative
point counter present throughout the session at the top of the screen, and a point was added
following the consummatory response. After the point was delivered, the rectangle reappeared in
the middle of the screen. Points were not exchanged for backup reinforcers. The background
colors of the screen (yellow and blue) served as the contextual stimuli and changed from phase to
phase.
Procedure, Experimental Design, and Dependent Measures
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Each participant attended one virtual 60-min session with exposure to all three phases of
the renewal arrangement. Each phase was 15 min, and the remainder of the 60-min appointment
included informed consent at the beginning and a demographic questionnaire at the end. We
explained the informed consent form to the participant at the beginning of the Zoom session, and
the participant provided consent by typing their name in a box on Qualtrics. During the informed
consent process, we described expectations for the participant (e.g., keep pets away from
computer screen, limit distractions as much as possible, keep video on). Following informed
consent, we read the participant the following instructions: “The experiment involves a computer
task. There will be a point counter at the top of the screen. It is up to you to figure out how to
earn points. Do you have any questions?” The experimenter did not reveal any of the
contingencies of the experiment (e.g., the experimenter did not answer questions such as “why
am I not earning points anymore?”). The experimental design was a 3-phase ABC design that
included a baseline phase (Context A) in which the target response was reinforced, a DRO
treatment phase (Context B) to reduce the target response, and a renewal test phase (return to
Context A). The primary dependent measure was the frequency of mouse clicks on the target
response, which was automatically recorded and timestamped by the program and is reported as
the number of responses per min in each 15-min phase. The experimenter running the session
was available on Zoom for any questions or technology concerns but was on mute and had their
video off while the participant was engaged in the experimental task. Phases were associated
with different stimulus contexts, represented by different background colors of the screen.
Specifically, the color was yellow in Phases 1 and 3 (i.e., Context A) and blue in Phase 2 (i.e.,
Context B). At the end of the session, participants completed a demographic questionnaire
(Appendix A) via a Qualtrics survey. The questionnaire also included three open-ended
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questions that asked the participants to explain what they guessed was the purpose of the
experiment. We then read the following debriefing statement to the participant: “Thanks for
participating in this research. The purpose of this study was to look at patterns of behavior when
the ways to earn points change across the different screen colors. This computer program is set
up to be an analog of a clinical treatment that is commonly used in behavior analysis to reduce
undesirable behavior. The screen colors represent different physical locations that a client might
be in over time (e.g., a clinic, a school, home). We hope this study will inform clinical
interventions that have better long-term effects on behavior change. We are continuing to recruit
participants, so please do not share details about this session or the purpose of this project with
anyone. Do you have any questions?”
Baseline (Context A)
The background color during baseline was yellow. Clicking on the rectangle was
reinforced according to an FI-10 s schedule in which the first mouse click on the rectangle after
the 10-s interval elapsed resulted in the delivery of one point.
DRO (Context B)
In the DRO phase, one point was delivered following the omission of responding on the
target for the entirety of the 10-s omission interval. Each time mouse clicks on the target
response occurred, the DRO interval was reset, and the scheduled reinforcer was canceled. The
background color during the DRO phase was blue.
Renewal Test (Context A)
In the renewal test, the contingencies for the target response were the same as during the
DRO phase. To isolate the change in context, the only difference between the DRO phase and
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the renewal test was the background color, which returned to the same color as baseline (i.e.,
yellow).
Data Analysis
We analyzed the results via visual inspection of graphed data to compare responding in
the treatment and renewal test phases (see Figure 1 and 2). Renewal was defined as the number
of mouse clicks on the rectangle in any given minute of the renewal test exceeding the average
responses per min from the last 5 min of the DRO phase. We also calculated the proportion of
baseline responding in the renewal test for each participant by dividing the number of responses
in each minute of the 15-min renewal test by the mean number of responses from the last 5 min
of baseline (see Figures 3 and 4). The purpose of calculating the proportion of baseline was to
provide a relative measure of renewal compared to each individual participant’s baseline
response rate. The number of reinforcers delivered in each min was also recorded by the
computer program (see Figure 5 for included datasets and Figure 6 for excluded datasets).
Untargeted behavior was defined as mouse clicks on the background screen and was visually
analyzed for all included datasets (see Figure 7). Consummatory response time was defined as
the time from the presentation of the consummatory message on the screen (i.e., the “collect
point” box) to the participant clicking on the “collect point” message and the box disappearing.
Consummatory response time was analyzed to determine if there were differences between time
spent with the consummatory message across phases (i.e., if consummatory response time was
greater in the DRO phase compared to baseline) because increased consummatory response time
across the session may indicate participant fatigue. A participant’s data were excluded from data
analysis if the participant engaged in less than 10 responses per min or a downward trend in
graphed data in the last 5 min, as this would suggest that points do not function as reinforcers for
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that participant. Data were also excluded from data analysis if responding was not suppressed in
the DRO treatment phase.
Results
Ten participants completed the study; six data sets were included, and datasets from four
participants were excluded from the analysis based on the exclusion criteria. Participant 302 was
excluded because responding was not suppressed in the DRO treatment phase, Participant 304
was excluded because responses per min were trending downward in the last 5 min of baseline,
and Participants 305 and 309 were excluded because the average responses per min in the last 5
min of baseline was less than 10 (see Figure 1 for all excluded participant target response data
and Appendix B for supplemental graphs for these datasets). Renewal of target responding
occurred for all six included participants (see Figure 2). All included participants acquired the
target response in the baseline phase, and the mean number of responses per min in the last 5 min
of baseline ranged from 33.2–176.8. In the DRO treatment phase, responding decreased from
baseline levels to near-zero levels for all included participants. Mean responses per min in the
last 5 min of the DRO treatment phase ranged from 0–0.442. The proportion of baseline data
provide values that measure the occurrence of renewal relative to each participant’s baseline
response rate as baseline responding differed across participants. The proportion of baseline
during the minutes in which renewal occurred ranged from 0.27–0.86, indicating that the
intensity of renewal varied across participants as measured by a comparison to baseline
responding. The mean number of reinforcers delivered per minute ranged from 4–4.87 in
baseline, 2.8–4.87 during the DRO treatment phase, and 4.27–5.27 during the renewal test phase
for included datasets (see Figure 3). The number of reinforcers delivered per min was similar
across included datasets. In general, when phases changed from baseline to DRO treatment or
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from DRO treatment to the renewal test, obtained reinforcer delivery decreased temporarily but
stabilized to levels similar to baseline as target responding stabilized. There was a negative
relation between the number of reinforcers delivered and level of renewal across minutes (i.e.,
when target responding was high in the renewal test, the number of reinforcers was low).
Untargeted behavior (i.e., clicks on the background screen) varied across participants and is
reported below for each participant. Total consummatory response time did not vary
systematically across phases or participants and ranged from 3.72–7.16 min (1.20–2.51 min for
Phase 1; .56–2.19 min for Phase 2; 1.13–2.73 min for Phase 3; see Table 1).
In the baseline phase for Participant 301, mouse clicks on the target rectangle were
elevated but variable (i.e., rate changed across the phase but lacked an upward or downward
trend), with the highest number of responses per min occurring in the last 5 min of baseline at an
average of 58.8 responses per min (see Figure 2). Responding during the first min of the DRO
phase (i.e., 164 responses) was higher than any min of the baseline phase (maximum responding
in the baseline phase was 134 clicks in min 12) and decreased to zero responses per min by the
fourth min of the DRO phase and remained under two clicks per min for the rest of the phase.
Mouse clicks occurred an average of 0.44 times per min in the last five min of the DRO
treatment phase. The number of responses per min in the renewal test ranged from 0–37 and
proportion of baseline ranged from 0–0.63. Renewal occurred in the first min of the renewal test
(proportion of baseline = 0.63; see Figure 4), then responding reduced to zero or near-zero levels
for the remainder of the phase. During baseline, untargeted responding was variable (range, 0–
75) and occurred a mean of 0.6 times per min during the last 5 min of the phase (see Figure 5).
Untargeted behavior (i.e., background clicks) occurred 10–24 times per min during the first 3
min of the phase and then decreased to near-zero rates for the remainder of the phase, with no
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occurrences in the last 3 min of the phase. During the first min of the renewal test, untargeted
behavior initially increased to 9 clicks in the first min and then decreased to near-zero levels.
Untargeted behavior generally increased when renewal occurred.
For Participant 303, target responding was elevated above zero for the entirety of the
baseline phase, and Participant 303 engaged in an average of 74.6 responses per min in the last
five min of baseline (see Figure 2). Responses per min trended downward in min 10–13 but
increased to the highest rate of responding for the entire session in minutes 14 (157 responses)
and 15 (138 responses). At the beginning of the DRO treatment phase, responding was elevated
at an average of 75.4 responses per min for the first five min. Responding decreased to zero
responses per min by min 8 and remained at zero for the rest of the phase; therefore, average
responses per min in the last 5 min of the DRO phase was zero. In the first min of the renewal
test phase, one target response occurred, then responding returned to zero for the remainder of
the session. The maximum proportion of baseline was 0.01 for Participant 303 (see Figure 4).
Responding in the renewal test exceeded responding from the end of the treatment phase;
therefore, renewal did occur. The pattern of untargeted behavior was similar to the pattern of
target behavior across all three phases, although the level of target responding was generally
higher than untargeted responding (see Figure 5). Background clicks occurred variably in
baseline and ranged from 0–18 times per min. Untargeted behavior occurred between 6 and 30
times in the first 6 min of the DRO treatment phase and then decreased to zero for the last 7 min
of the phase. Untargeted behavior did not occur in the renewal test phase.
For Participant 306, target responding was variable but lacked an upward or downward
trend in baseline, with responding ranging from 10 to 50 responses per min (see Figure 2). Target
responding occurred an average of 33.2 times per min in the last 5 min of baseline. Responding
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in the first three min of the DRO treatment phase was similar to baseline responding, ranging
from 34–44 and then increased to 84 responses in the fourth min. Responding then trended
downward and suppressed to zero by the eighth min of the DRO treatment phase. Mean
responses per min was zero for the last 5 min of the DRO treatment. Renewal occurred in the
first min of the renewal test phase with nine clicks on the target rectangle. The maximum
proportion of baseline was 0.27 (see Figure 4). Untargeted behavior occurred at a low rate
throughout the baseline phase (range 1–16) and the first 6 min of the DRO treatment phase
(range 0–4; see Figure 5). Then untargeted behavior increased and remained elevated for the
remainder of the session. The mean number of responses per min was 80 responses per min for
the last 5 min of the DRO treatment phase and 82.2 for the entire renewal test phase.
Participant 307 engaged in a mean of 141.2 target responses per min in the last five min
of baseline (see Figure 2) and trended upward during the last 10 min the phase. In the DRO
treatment phase, 145 and 57 responses occurred in the first and second min, respectively.
Responding then decreased to zero in the third min and remained at zero for the rest of the phase.
Participant 307 clicked 122 times on the target rectangle in the first min of the renewal test
phase; therefore, renewal did occur. Responding did not occur for the rest of the test phase. The
proportion of baseline for the first min of the renewal test was 0.86 (see Figure 4). Untargeted
behavior was elevated in the first four min of the baseline phase (range, 15–33) before
decreasing to near-zero levels (see Figure 5). Untargeted behavior occurred in the first 3 min of
the DRO treatment phase 14 times, 50 times, and 29 times, respectively. Untargeted behavior did
not occur for the remainder of the DRO treatment phase. Background clicks occurred 4 times in
the first min of the renewal test and 1 time in the fourth min of the renewal test but did not occur
in any other min of the renewal test.
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For Participant 308, target responding in baseline was variable but elevated for the
entirety of the phase (range 66–203). Participant 308 clicked on the target rectangle a mean of
172.8 times per min in the last five min of baseline (see Figure 2). Responding in the first five
min of the DRO treatment phase trended downward during the first 3 min, reached zero by the
third min, and stayed at zero for the remainder of the phase. The average responses per min was
zero in the last five min of the DRO treatment phase. The responses per min in the renewal test
ranged from 0–115 and proportion of baseline ranged from 0–0.67 (see Figure 4). In the first min
of the renewal test, Participant 308 responded 115 times on the target rectangle and then
decreased to zero responses for min 3 and min 4. Responding was variable for the rest of the
phase, ranging from zero to 32 responses per min. Mouse clicks on the target rectangle increased
to six in min 39 and 32 clicks in min 43. Therefore, renewal occurred for Participant 308, and
responding persisted at lower levels throughout the renewal test phase. Untargeted behavior
occurred sporadically at low levels throughout the baseline phase (range 0–12), then increased in
the first 4 min of the DRO treatment phase (range 14–102) before decreasing and stabilizing at 0
responses per min at the end of the phase (see Figure 5). In the renewal test phase, untargeted
behavior increased at the beginning of the phase and occurred 17 times in the first min and 39
times in the second min. Similar to target responding in the renewal test, untargeted behavior
occurred at elevated levels across the renewal test phase (e.g., 44 times in min 39; 18 times in
min 43). When renewal occurred for Participant 308, untargeted behavior generally increased in
the same min, suggesting that there was a positive relation between renewal of target responding
and occurrence of untargeted behavior for this participant.
For Participant 310, target responding was lowest in the beginning of the baseline phase
and increased rapidly to over 200 responses by the third min (see Figure 2). In the last five min
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of baseline, an average of 176.8 responses occurred per min. In the DRO treatment phase,
responding was above 200 responses for the first min and quickly decreased to zero responses by
the second min. Responding remained low for the rest of the DRO treatment phase and the
average responses per min in the last five min was zero. Participant 310 clicked 92 times on the
target rectangle in the first minute of the renewal test phase, therefore renewal did occur.
Participant 310 did not click on the target rectangle for the rest of the phase. The maximum
proportion of baseline was 0.52 in the first min of the renewal test (see Figure 4). Untargeted
behavior occurred 23 times in min 1 and 15 times in min 2, then decreased to zero or near-zero
levels for the remainder of the baseline phase (see Figure 5). In the DRO treatment phase,
untargeted behavior increased temporarily (i.e., 9 times in min 16 and 34 times in min 17), then
decreased to near-zero levels for the remainder of the phase. In the renewal test phase, untargeted
behavior occurred at low rates at the beginning of the phase but increased variably from min 39
to the end of the phase, with the maximum occurrence at 36 times in min 40. Untargeted
behavior occurred for Participant 310 but did not seem to directly relate to the occurrence of
renewal.
Discussion
The purpose of this study was to assess the occurrence of renewal of target responding
following omission training (i.e., DRO). All six participants for whom datasets were included in
the analysis acquired the target response in baseline, and responding was suppressed in the
second phase during the DRO treatment phase. In general, the data from this study are evidence
of renewal following a DRO treatment for all six participants. The proportion of baseline
responding for the minutes in which renewal occurred varied across participants, which is
indicative of varying levels of renewal relative to individual baseline responding. The results of
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this study are consistent with previous human-operant research that has assessed renewal
following omission training according to a DRO schedule (Vila et al., 2020). This study
extended Vila et al. by demonstrating renewal when context is isolated as the only variable that
changes from treatment to the renewal test, which provides additional evidence that a context
change can result in relapse. Additionally, this study demonstrates that systematic humanoperant data can be collected using a virtual approach by providing the participant remote control
of a program via Zoom. Orderly data were obtained despite the extraneous variables that may be
present in the participant’s environment (e.g., pets, roommates, or family members). This study
contributes to a modest collection of studies that have employed remote data collection using a
free-operant task (e.g., Robinson & Kelley, 2020).
The data from the current study are consistent with previous research that suggests that
renewal is transient such that responding returns to stable treatment levels following renewal
(e.g., Muething et al., 2020). Renewal occurred for all six participants and was temporary for
five participants. Renewal for Participant 308 was somewhat persistent across the renewal test
phase such that responding initially decreased to zero in the third min of the renewal test and
then persisted variably throughout the remainder of the phase. Even though renewal was
persistent relative to other participants, rate of responding in the renewal test phase was still
lower than responding in baseline, which still demonstrates an overall reduction in target
responding from baseline to post-treatment conditions. Due to the standardized phase duration at
15 min, it is unknown to what extent target responding would have persisted if the phase would
have been longer. The transient nature of renewal has implications for clinical settings and the
treatment of challenging behavior. Clinicians are often warned that relapse can occur when
reinforcement conditions are worsened (i.e., resurgence, Lattal & St. Peter Pipkin, 2009), but the
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emerging literature on renewal suggests that clinicians and caregivers should also prepare for
relapse following a context change, even when the treatment is still implemented with high
integrity. However, with the transient nature of renewal, clinicians and other caregivers can be
encouraged that renewal of challenging behavior is likely to be temporary and lower than
baseline levels. Practitioners should emphasize that it is important to maintain the treatment
contingencies during the increase in challenging behavior.
There are some limitations to this study. First, this experiment did not include a
replication of phases (i.e., each phase only occurred once for each participant); demonstrating a
replication of renewal following DRO would increase confidence in the interpretation that the
DRO schedule decreased target responses and that context changes resulted in renewal. One way
to incorporate replication would be to repeat each of these phases with their respective
contingencies (i.e., an ABCABC reversal design). However, drawing parallels from the
resurgence literature, less renewal might be expected in a replication via an ABCABC reversal
design (Kestner et al., 2018). A second limitation was the difficulty observing or controlling
distractions in the participants’ environment with the virtual arrangement (e.g., pets, other
people, weather, competing contingencies such as phone usage). Conducting this research in a
laboratory setting in person would increase control of potentially confounding variables, which
could provide more confidence that responding was not influenced by extraneous variables in the
participants’ physical environment. However, conducting human-operant research virtually was
also a strength of this study as it increased efficiency and decreased cost. Considering the
benefits, further analysis of virtual arrangements of human-operant research is a worthwhile area.
Future research may assess ways to control for extraneous environmental variables during
remote sessions. Third, the extent to which these findings would generalize to clinical settings is

RENEWAL FOLLOWING DRO

20

unknown because many of the conditions arranged in laboratory settings are unlike naturalistic
variables (e.g., the target response is an arbitrary analog to challenging behavior). Humanoperant arrangements allow experimenters to analyze relations between independent and
dependent variables in a highly controlled setting, but when translated to clinical settings, some
extraneous variables can be more difficult to control (e.g., integrity of treatment implementation,
responses from peers in classroom settings). However, previous basic laboratory and
translational research of relapse have demonstrated continuity with clinical applications. In one
example described previously, Nevin et al. (2016) conducted a basic laboratory analysis of
resurgence and reinstatement with pigeons in one experiment and a similar procedure with
human subjects that engaged in challenging behavior, and the results demonstrated parallel
relapse trends across translational and clinical analyses. Translational analyses of behavioral
processes are important for bridging the gap between basic research and clinical application (see
Critchfield, 2011 for a discussion). The translational nature of the current study extends renewal
with DRO that has been previously demonstrated in basic laboratories to human subjects while
still maintaining high laboratory control to isolate basic processes.
Future Directions
Future research should continue to assess the conditions under which renewal occurs
following DRO and other behavior reduction intervention strategies. The present study assessed
renewal when the renewal test occurred in the same context as baseline (i.e., ABA renewal).
There are no published studies to date investigating renewal in an ABC or AAB renewal
paradigm following a DRO treatment. Studying different renewal paradigms following omission
training will be important because context changes that occur in natural environments often
mimic arrangements other than ABA renewal (e.g., AAB or ABC renewal). Future research
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should arrange contexts to assess ABC renewal by measuring target behavior in one context for
baseline (e.g., home), a new context for treatment (e.g., clinic), and a third novel context for the
renewal test (e.g., school) to better understand how multiple context changes impact the
occurrence of renewal. For AAB renewal, the context in baseline and treatment is the same (e.g.,
home for both phases) and renewal is assessed in a novel, second context (e.g., school). These
studies would provide additional information about the occurrence of relapse following DRO
given context changes that differ from ABA renewal but represent patterns of change that likely
occur in clinical populations.
Additional research should also compare the occurrence of renewal following various
commonly implemented treatments. Future research should compare the prevalence and intensity
of renewal following DRA and DRO; identifying interventions that are more resistant to relapse
of challenging behavior is crucial to promoting maintenance and generalization of therapeutic
effects. Previous translational relapse literature has compared resurgence following a DRO
treatment and a DRA treatment using multiple schedules of reinforcement (Romano & St. Peter,
2017). More resurgence occurred following the DRO intervention relative to the DRA
intervention. Similar comparisons could be conducted for renewal, specifically isolating changes
in context across phases to better inform which treatments might be more resistant to relapse.
Data demonstrating more resurgence and renewal following a DRO treatment might suggest that
a DRA treatment is a better option for maintaining treatment effects and decreasing the
likelihood of relapse in the form of resurgence and renewal.
In addition to studying relapse with other treatment strategies, further analysis of the
treatment effects of DRO procedures is also warranted. Previous research has analyzed the active
components of DRO that facilitate decreases in challenging behavior. Mechanisms of behavior
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change in DRO might include extinction by withholding a reinforcer after the occurrence of
problem behavior, negative punishment because the delivery of the reinforcer is canceled or
postponed contingent on problem behavior, or adventitious reinforcement of untargeted behavior
that might occur in close temporal proximity to the delivery of the reinforcer according to the
DRO schedule (Jessel & Ingvarsson, 2016). As the name DRO suggests, untargeted behavior can
be defined as any “other” response that occurs during a DRO treatment that is not the target
response (Poling & Ryan, 1982). In a human-operant laboratory setting, examples of untargeted
behavior might include clicking on the background of the screen, clicking on the point counter,
or pressing keys on the keyboard. In a clinical setting, untargeted behavior could include new or
different topographies of challenging behavior not targeted in treatment or the emergence of
appropriate behavior that is not specifically reinforced (e.g., task engagement or mands for
preferred items). There is evidence to suggest that adventitious reinforcement of untargeted
behavior is a mechanism of behavior reduction in DRO treatment based on increases in
untargeted behavior when a DRO is implemented (e.g., Jessel et al., 2015; Rey et al., 2020a). As
such, the increase in untargeted behavior could act as a replacement for challenging behavior
reduced during treatment. For example, Participant 306 in this study engaged in stable
responding on the screen background which suggests that adventitious reinforcement of
untargeted behavior occurred. However, untargeted behavior did not occur consistently for the
other five participants in this study. If untargeted behavior occurs for sustained periods,
researchers and practitioners might be interested in whether the untargeted behavior is a new or
different topography of problem behavior or appropriate behavior.
Evaluations of the occurrence of untargeted behavior across contexts in a renewal
paradigm may provide additional information on potential relations between untargeted
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responding and renewal of the target response. It is possible that the occurrence of untargeted
behavior is related to the level of renewal (e.g., less renewal may occur if untargeted behavior is
elevated in the treatment phase or the renewal test). In this study, we measured one possible
topography of untargeted behavior in the form of background clicks, but it is possible that
participants engaged in unmeasured topographies of untargeted behavior. Future studies could
compare the occurrence or intensity of renewal following DRO while simultaneously measuring
a wider set of potential topographies of untargeted behavior. In the present study, both positive
and negative relations between the occurrence of renewal and untargeted behavior in the renewal
test were demonstrated, but the nature of the possible association was not further explored, and
future investigation of these relations is warranted.
Non-human animal and human-operant translational studies of renewal are common in
the literature, but less research has assessed the prevalence of renewal in clinical settings
following socially significant reduction of problem behavior (Muething et al., 2020). Studying
renewal in clinical settings will provide information critical to improving clinical practice. For
example, future research should evaluate the interplay between treatment integrity and renewal.
Challenging behavior may relapse when treatment integrity decreases (Volkert et al., 2009) and
conversely, treatment integrity may decrease when challenging behavior increases or relapses
(Mitteer et al., 2018). Future research should assess how various treatment integrity levels during
treatment or during a relapse test might impact renewal and other forms of relapse. In addition to
studying the prevalence of renewal and the conditions under which renewal occurs in clinical
settings, future research should also work to identify methods for mitigating the occurrence of
renewal or decreasing the intensity or persistence of renewal of challenging behavior. For
example, one possible mitigation technique is implementing treatment in multiple contexts,
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which may decrease the occurrence of renewal when context changes following treatment and
contribute to generalization of treatment effects.
In clinical populations, context changes occur when alternating between therapy settings,
home, and extracurricular activities. Relapse has been demonstrated following a context change
from therapy to home settings (Saini et al., 2018), and recent research is increasingly
investigating methods for reducing renewal in human populations (Sullivan et al., 2018).
Sullivan et al. compared a traditional (i.e., sequential) model of renewal (ABA) with a
nonsequential model of renewal (ACA), in which the C phase rapidly alternated between
baseline and treatment schedules of reinforcement to more closely approximate repeated context
changes during clinical treatment. For example, a client may attend outpatient treatment each
weekday and return home following treatment sessions. The client is frequently alternating
between treatment and home (i.e., baseline) contexts multiple times each day. Sullivan et al.
found that renewal occurred at similar levels for both sequential and nonsequential renewal,
suggesting that relapse during context changes is widespread and more complicated than a
sequential progression from baseline to treatment and post-treatment environments and that
additional research investigating when renewal occurs in human populations is imperative.
The current experiment demonstrates the occurrence of renewal following reduction of
behavior using omission training according to a DRO 10-s schedule. Renewal occurred for all six
participants, and for five out of six participants, renewal was transient. This study and the
growing body of literature on renewal following common clinical procedures highlight that
renewal is common and clinicians should be prepared for renewal when context changes after
treatment. Researchers and practitioners should continue to assess when renewal occurs, under
what context changes it occurs, which interventions precede its occurrence, which interventions
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yield more or less intense levels of renewal, and how to mitigate renewal following common
behavior reduction treatments such as differential reinforcement.
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Figure 1

Note. The number of target responses in each min of the baseline, DRO treatment, and renewal
test phases for all excluded participants. Please note that the y-axis scale varies across graphs
based on participant responding.
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Figure 2

Note. Number of target responses in each min of baseline, DRO treatment, and renewal test
phases for all participants included in data analysis. Please note the variable y-axis scales across
graphs.
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Figure 3

Note. The number of reinforcers delivered in each min of the baseline, DRO, and renewal test
phases for all included participants.
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Note. The proportion of baseline for the last min of the DRO treatment phase and all 15 min of
the renewal test phase for all participants included in data analysis.
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Figure 5

Note. Number of untargeted responses in each min of the baseline, DRO treatment, and renewal
test phases for all included datasets. Please note that the y-axis differs across graphs based on
variable rates of participant responding.
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Table 1
Consummatory Response Time
Participant
301
302
303
304
305
306
307
308
309
310

Included or
Excluded
Included
Excluded
Included
Excluded
Excluded
Included
Included
Included
Excluded
Included

Time with CM
in Phase 1
1.87
1.27
1.34
2.51
1.20
1.46
1.38
1.61
1.43
2.08

Time with CM
in Phase 2
2.04
1.60
0.56
2.19
1.64
1.52
1.21
2.17
1.18
2.00

Time with CM
in Phase 3
1.90
2.58
1.87
2.46
1.75
2.19
1.13
2.17
1.38
2.73

Total Time
with CM
5.81
5.45
3.77
7.16
4.59
5.17
3.72
5.95
3.99
6.81

Note. The time spent with the consummatory response present and participants engaging in the
consummatory response (i.e., clicking the “collect point” message) for each phase and the total
time for the whole session.
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Appendix A

Questionnaire
For research staff:
Participant ID: ____________

Date: ____________ Time: ____________

RA name: ____________________________________
Instructions: The purpose of the following questions is to collect information about your
demographic variables and your impressions of the study. Please skip any questions that do not
feel comfortable answering.

What is your age in years? _________
• I prefer to not answer

How do you currently describe your gender identity?
___________________________________________________
• I prefer to not answer

How do you identify your racial and ethnic background? Please select all that apply to you:
• American Indian or Alaska Native
• Asian
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• Black or African American
• Hispanic, Latinx/Latine, or Spanish Origin
• Middle Eastern or North African
• Native Hawaiian or Other Pacific Islander
• White
• Other/prefer to self-describe: ______________________________________
• Unknown
• I prefer to not answer

Do you have (or suspect that you have) a color vision deficiency? If yes, what form?

Please describe what happened and what you did during the session(s).

Please describe any strategies that you may have used to earn points. Did any of your strategies
change across the experiment?

What do you think we are trying to learn from this study?
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Appendix B

Note. The number of reinforcers delivered in each min of the baseline, DRO treatment, and
renewal test phases for all excluded participants.
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Note. The proportion of baseline for the last min of treatment and the 15 min of the renewal test
for all excluded participants. Please note that the y-axis scale varies across graphs.

